MEL Ameliorates Post-SAH Cerebral Vasospasm by Affecting the Expression of Enos and HIF1α Via H19/miR-138/eNOS/NO and H19/miR-675/HIF1α.

Guoqiang Hou,Hongjin Chen,Yuhua Yin,Yaohua Pan,Xiaohua Zhang,Feng Jia
DOI: https://doi.org/10.1016/j.omtn.2019.12.002
2020-01-01
Abstract:Melatonin (MEL) has been demonstrated to exert a protective effect against subarachnoid hemorrhage (SAH), and nitric oxide (NO) has been shown to play an important role in the pathogenesis of vasospasm. This study aims to explore the underlying molecular mechanisms of MEL in the control of vasospasm following SAH. MEL administration attenuates SAH-induced vasospasm and neurobehavioral deficits. Expressions of H19, eNOS, and miR-675 are low in the SAH group, while expressions of miR-138 and HIF1 alpha are high in the SAH group. Also, MEL treatment upon SAH rats completely restores the dysregulation of H19, eNOS, miR-675, miR-138, and HIF1 alpha to their normal levels. Moreover, MEL dose dependently increases the luciferase activity of H19 promoter and hence the expression of H19. Additionally, H19 directly targets miR-675 and miR-138 to increase miR-675 expression and inhibit miR-138 expression. As virtual target genes of miR-675 and miR-138, respectively, HIF1 alpha and eNOS are also regulated by the treatment with MEL. In particular, MEL treatment increases the expression of miR-675 and eNOS level while decreasing the expression of miR-138 and HIF1 alpha in a dose dependent manner. Our study found that MEL ameliorates post-SAH vasospasm by regulating the expression of eNOS and HIF1 alpha via the H19/miR-138/eNOS/NO and H19/miR-675/HIF1 alpha signaling pathways.
What problem does this paper attempt to address?